Please login to the form below
Lyme disease
This page shows the latest Lyme disease news and features for those working in and with pharma, biotech and healthcare.
Pfizer and Valneva report six-month antibody persistence data for Lyme disease vaccine
This is the first time that antibody persistence data has been reported in paediatric populations for VLA15, which is also the only Lyme disease vaccine candidate currently in clinical development. ... Lyme disease is a systemic infection transmitted to
Latest news
-
Valneva and Pfizer initiate phase 3 Lyme disease vaccine study
areas where Lyme disease is highly endemic, including the US, Germany, Poland, Finland, Sweden and the Netherlands. ... Lyme disease is a systemic infection transmitted to people by infected Ixodes ticks carrying Borrelia Burgdorferi bacteria.
-
Pfizer to buy 8.1% stake in Valneva in support of joint Lyme disease programme
Lyme disease is a systemic infection transmitted to people by infected Ixodes ticks carrying Borrelia Burgdorferi bacteria. ... Lyme disease is spreading and represents a high unmet medical need which impacts the lives of millions of people in the
-
Pfizer and Valneva announce positive phase 2 paediatric data for lyme disease vaccine
Pfizer and Valneva have announced positive phase 2 paediatric results for their Lyme disease vaccine candidate, VLA15. ... Lyme disease is a systemic infection transmitted to people by infected Ixodes ticks carrying Borreliaburgdorferi bacteria.
-
Positive data for Lyme disease booster vaccine
A booster shot of Valneva/Pfizer’s VLA15 vaccine candidate against tick-borne Lyme disease demonstrates a strong immune response. ... We look forward to continue our development efforts in our quest to potentially protect people from Lyme disease in
-
Google to respond to health queries with treatment information
Coming up behind were health searches for Asperger's, ALS, Lupus and then diabetes, with Lyme disease, typhus and respiratory symptoms rounding out the top ten searches in 2014.
More from news
Approximately 5 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
Pharma deals during July 2014
Cosmo Technologies is an Irish-domiciled subsidiary of Italian-based Cosmo Pharmaceuticals, which has a focus in gastrointestinal disease and dermatology. ... TBE). The deal includes the associated production facilities for these two marketed vaccines
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Australian Flu and the dilemma of naming diseases
as disease carriers, and creating negative connections between the name and the country. ... Naming diseases after people, places and animals has been common practice throughout the world for centuries, from the more current examples of Swine flu and
-
To track disease, follow the money
The tracker gives a daily snapshot of 15 diseases including cold, flu, Lyme disease and glandular fever, and the data can be further broken down by age group and severity. ... Which prompts the question, how sustainable is the idea of tracking disease
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Manager
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- MHRA to introduce new UK clinical trials framework
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- PMGroup announces launch of new recruitment platform PharmaRole
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- BioNTech reveals plans to spend about €1bn more on research and development this year
- AstraZeneca’s mild combination asthma reliever approved in UK
- Virtual Patient Engagement Program: A Customer Story
- Putting Skin in the Game at AAD 2023
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- MHRA to introduce new UK clinical trials framework
- Sanofi/Regeneron’s Dupixent approved by EC for atopic dermatitis in children
- Inizio appoints Stefanie Christmas as global head of DE&I
- The Considered appoints Bam Zahraie as chief experience officer
PMHub
IPG Health Medical Communications
We are the world's most celebrated and awarded Medical Communications agencies. We are 800 experts obsessed with combining science, creativity...
Latest intelligence
- Virtual Patient Engagement Program: A Customer Story
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
